Synonyms
- Cerebrospinal Fluid IgG
- CSF IgG
- CSF Immunoglobulin G
- IgG, CSF
- IgG, Quantitative, CSF
- Immunoglobulin G, CSF
Test Includes
Quantitation of CSF IgG
Special Instructions
The third tube of a routinely obtained three-tube set of CSF should be used for CSF IgG study.
Expected Turnaround Time
3 - 5 days
Turnaround time is defined as the usual number of days from the date of pickup of a specimen for testing to when the result is released to the ordering provider. In some cases, additional time should be allowed for additional confirmatory or additional reflex tests. Testing schedules may vary.
Related Documents
Specimen Requirements
Specimen
Cerebrospinal fluid (CSF)
Volume
0.5 mL
Minimum Volume
0.25 mL
Container
Sterile container
Storage Instructions
Room temperature
Stability Requirements
Temperature | Period |
|---|---|
Room temperature | 14 days |
Refrigerated | 14 days |
Frozen | 14 days |
Freeze/thaw cycles | Stable x2 |
Causes for Rejection
Excessive blood in CSF
Test Details
Use
Evaluate central nervous system involvement by infection, neoplasm, or primary neurologic disease (in particular, multiple sclerosis)
Limitations
Normal levels do not exclude disease; clinical correlation must be applied.
Methodology
Immunologic
Reference Interval
See table.
Age | Male (mg/dL) | Female (mg/dL) |
|---|---|---|
0 to 1 y | Not established | Not established |
2 to 12 y | 0.0−4.3 | 0.0−4.3 |
13 to 17 y | 0.0−5.2 | 0.0−5.2 |
>17 y | 0.0−10.3 | 0.0−6.7 |
Additional Information
Cerebrospinal fluid protein is elevated in many conditions which affect the central nervous system primarily or secondarily. In inflammatory or destructive processes in which serum leaks into CSF, both IgG and albumin will be present in the CSF in increased amounts. Since albumin is not, but immunoglobulins are, synthesized in the central nervous system, a relative increase in CSF IgG indicates presence of a process involving the central nervous system primarily, in particular multiple sclerosis.
IgG showed marked elevation (>16 mg/dL) in 36% of MS patients with only 1% of non-MS controls having this degree of increase. In the slightly elevated category (11% to 16%) however, there was considerable overlap with 38% of MS patients and 27% of non-MS patients falling into this category. While MS patients are maintained on ACTH and/or steroid therapy or during remission, CSF IgG levels decrease but generally remain significantly elevated.
LOINC® Map
| Order Code | Order Code Name | Order Loinc | Result Code | Result Code Name | UofM | Result LOINC |
|---|---|---|---|---|---|---|
| 012211 | Immunoglobulin G, Quant, CSF | 2464-6 | 012212 | IgG, Quant, CSF | mg/dL | 2464-6 |
© 2021 Laboratory Corporation of America® Holdings and Lexi-Comp Inc. All Rights Reserved.
CPT Statement/Profile Statement
The LOINC® codes are copyright © 1994-2021, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. Permission is granted in perpetuity, without payment of license fees or royalties, to use, copy, or distribute the LOINC® codes for any commercial or non-commercial purpose, subject to the terms under the license agreement found at https://loinc.org/license/. Additional information regarding LOINC® codes can be found at LOINC.org, including the LOINC Manual, which can be downloaded at LOINC.org/downloads/files/LOINCManual.pdf